Back

Catalytically distinct IDH1 mutants tune phenotype severity in tumor models

Adam, M. A. A.; Robinson, M.; Schwartz, A. V.; Wells, G. A.; Hoang, A.; Albekioni, E.; Gallo, C.; Chao, G.; Weeks, J.; Quichocho, G.; George, U. Z.; House, C. D.; Turcan, S.; Sohl, C. D.

2024-09-14 genomics
10.1101/2024.04.22.590655 bioRxiv
Show abstract

Mutations in isocitrate dehydrogenase 1 (IDH1) impart a neomorphic reaction that produces D-2-hydroxyglutarate (D2HG), which can inhibit DNA demethylases to drive tumorigenesis. Mutations affect residue R132 and display distinct catalytic profiles for D2HG production. We show that catalytic efficiency of D2HG production is greater in IDH1 R132Q than R132H mutants, and expression of R132Q in cellular and xenograft models leads to higher D2HG concentrations in cells, tumors, and sera compared to R132H. Though expression of IDH1 R132Q leads to hypermethylation in DNA damage pathways, DNA hypomethylation is more notable when compared to R132H expression. Transcriptome analysis shows increased expression of many pro-tumor pathways upon expression of IDH1 R132Q versus R132H, including transcripts of EGFR and PI3K signaling pathways. Thus, IDH1 mutants appear to modulate D2HG levels via altered catalysis, resulting in distinct epigenetic and transcriptomic consequences where higher D2HG levels appear to be associated with more aggressive tumors.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Nature Communications
○ 5641 papers in training set
Top 9%
18.5%
Similar papers in this journal
2
eLife
● 5828 papers in training set
Top 19%
6.3%
Similar papers in this journal
3
Cell Reports
○ 1498 papers in training set
Top 5%
6.3%
Similar papers in this journal
4
Journal of Biological Chemistry
○ 690 papers in training set
Top 2%
5.5%
Similar papers in this journal
5
Scientific Reports
○ 3612 papers in training set
Top 22%
4.3%
Similar papers in this journal
6
JCI Insight
● 277 papers in training set
Top 2%
3.4%
7
Cancer Research
● 130 papers in training set
Top 1%
3.2%
8
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 16%
3.2%
50% of probability mass above
9
Clinical Cancer Research
● 64 papers in training set
Top 0.7%
3.1%
10
PLOS Genetics
● 862 papers in training set
Top 5%
2.6%
11
Science Advances
● 1243 papers in training set
Top 15%
2.4%
12
The American Journal of Human Genetics
○ 234 papers in training set
Top 2%
2.4%
13
Acta Neuropathologica
○ 58 papers in training set
Top 0.8%
1.9%
14
Communications Biology
○ 993 papers in training set
Top 15%
1.7%
15
Genome Biology
○ 637 papers in training set
Top 7%
1.3%
16
Cancers
○ 213 papers in training set
Top 3%
1.3%
17
Life Science Alliance
● 285 papers in training set
Top 5%
1.1%
18
Genome Research
● 468 papers in training set
Top 5%
1.0%
19
JCO Precision Oncology
● 14 papers in training set
Top 0.3%
1.0%
20
iScience
○ 1154 papers in training set
Top 30%
1.0%
21
Cancer Cell
○ 42 papers in training set
Top 1%
0.9%
22
Human Molecular Genetics
◐ 141 papers in training set
Top 3%
0.8%
23
Cell Genomics
○ 172 papers in training set
Top 4%
0.8%
24
Brain
◐ 168 papers in training set
Top 3%
0.8%
25
Genome Medicine
○ 183 papers in training set
Top 5%
0.8%
26
Nucleic Acids Research
◐ 1281 papers in training set
Top 13%
0.8%
27
Journal of Clinical Investigation
● 179 papers in training set
Top 6%
0.8%
28
Neuro-Oncology
◐ 36 papers in training set
Top 0.6%
0.8%
29
Molecular Cancer Research
● 49 papers in training set
Top 2%
0.6%
30
Molecular Systems Biology
○ 162 papers in training set
Top 4%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.